Superstar Cynthia Hsu K99/R00 awardee ⁦NIAAA News⁩ ⁦UCSD Gastroenterology⁩ - we are beyond proud of you and in awe of your hard work and dedication to your research!! ⁦American Gastroenterological Association (AGA)⁩ ⁦AASLD⁩ ⁦UC San Diego Health Sciences⁩ ⁦San Diego Digestive Diseases Research Center⁩

What is the natural history of MASLD?

What is the median survival after a first decompensating episode?

This study MASLD Research Center provides some answers Rohit Loomba Nabil Noureddin Alina Allen Veeral Ajmera roypounder.apt

onlinelibrary.wiley.com/doi/10.1111/ap…

Natural history of MASLD in a group of people who underwent MRE

💪Nabil Noureddin and Rohit Loomba

Amazing #MASLD debrief by Mazen Noureddin, MD, MHSc at #TLM2023 👏👏

#LiverTwitter

Echo what Dr. Hsu said! Would add Dr. Hsu is our fellowship and division hero. Always making positive impact on her patients, fellows and others! As a fellow, I am always learning from Cynthia Hsu UCSD Gastroenterology

A huge crowd learning from the king of NITs Mazen Noureddin, MD, MHSc. Envisioning a future without liver biopsies. #MASLD #TLM23 AASLD

My BFF Mazen Noureddin, MD, MHSc presenting on designing #MASLD trials in Children. BIG unmet need. PSPs are needed ASAP Madrigal Pharmaceuticals Novo Nordisk US Medical Inventiva Pharma akerotx Rohit Kohli (He/Him) Alina Allen Ali Aminian Jeff Schwimmer AASLD Elliot Tapper

So happy for my dear friend Mazen Noureddin Mazen Noureddin, MD, MHSc for the grand opening of his Houston Liver Institute and Houston Research Institute. Everything is bigger and better in Texas:) Arizona Liver Health Anita Kohli Ramon Bataller Alina Allen Jeffrey V. Lazarus Manal Abdelmalek Pinnacle Clinical Research

New player in MASH treatment. HU6 a mitochondrial uncoupler. Great PDFF reduction in 61 days only! In coll w VCU Stravitz-Sanyal Institute for Liver Disease Rivus Pharmaceuticals Meena Bansal Juan Pablo (JP) Arab, MD  Naim Alkhouri Naga Chalasani Elliot Tapper #livertiwtter

Way to lead Jenny Yang

Industry collaboration at its finest🤝

Cook Medical Ovesco Endoscopy FUJIFILM Healthcare Americas Corp. #ERBEUSA all came together to support the UCSD Gastroenterology fellows hands on.

Attendees were able to try everything from tattoo, APC, OTSC, Hemospray and more!

#GItwitter #fellows

ICYMI, in our latest issue, Daniel Huang and colleagues estimate the risk of hepatic decompensation and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease and type 2 diabetes

thelancet.com/journals/langa…

#LiverTwitter Daniel Huang Rohit Loomba

AASLD Foundation Awardee Spotlight: Cynthia L. Hsu, MD, PhD Cynthia Hsu
😎

At the core of our work are the talented researchers and clinicians who work tirelessly to find better treatments and more cures for liver diseases. aasldfoundation.org/awardee-spotli…
#LiverTwitter

Excited about this new grant - Clinical Trial Studying Possible New Treatment Option for Patients with NAFLD- collaboration between ⁦⁩ ⁦UCSD Gastroenterology⁩ & ⁦Novo Nordisk⁩ - ⁦UC San Diego Health⁩ ⁦⁩ ⁦Patty Maysent⁩ ⁦Christopher A. Longhurst⁩ health.ucsd.edu/news/press-rel…

📚 Read an incredible review by ⁦Cynthia Hsu &⁩ ⁦Bernd Schnabl⁩ on the fascinating connection between the gut, liver, and microbiota in health and liver disease. A must-read if you are interested in this cutting-edge research! #UCSanDiego nature.com/articles/s4157…

Absolutely- team that plays and eat together stays together UCSD Gastroenterology luminal luminaries versus liver lovers pick up basketball 🏀 followed by dinner— score 1:1 the finals will be in September Christopher A. Longhurst Patty Maysent AASLD American Gastroenterological Association (AGA) INASL Juan Pablo (JP) Arab, MD 

Type 2 diabetes increases the risk for hepatic decompensation and hepatocellular carcinoma among patients with nonalcoholic fatty liver disease. Study in The Lancet Gastroenterology & Hepatology. Daniel Huang Nabil Noureddin maral amangurbanova Tolga Gidener, MD Alina Allen Mazen Noureddin, MD, MHSc 

fal.cn/3ADRV

The academic year’s first UCSD Gastroenterology Grand Rounds with Rohit Loomba and Nabil Noureddin on the changing landscape of #NASH therapies, with Q&A moderated by Samir Gupta, MD

The development of clinically significant fibrosis in NASH is associated with worse liver-related outcomes, cardiovascular events, and death
#NAFLDsig #livertwitter